Restore and Protect Reproductive Care
The American Medical Women’s Association (AMWA) has advocated for comprehensive reproductive health throughout its history and remains committed to supporting reproductive rights for all patients, including access to safe and legal abortions.
The nuances and considerations involved in reproductive care go far beyond what can be addressed through public discourse. Just as other complex healthcare decisions cannot and should not be decided by politicians, our judicial system, or strangers, neither should decisions about pregnancy care. These are decisions that should be made by the patient in consultation with their physician or healthcare practitioner.
Legal restrictions to abortion care may have serious, life-altering consequences regarding treatment for ectopic pregnancy, miscarriage, fertility treatment, and maternal health risks. These are just some of the factors that impact the complex decision-making around pregnancy care. Physicians must be free to determine the best possible care informed by clinical training and evidence-based guidelines — unimpeded by legislative interference.
REPRODUCTIVE HEALTH COALITION
AMWA, in partnership with Doctors for America, co-founded the Reproductive Health Coalition, a wide-range of health professional associations and allied organizations that advocate with a unified voice to protect access to reproductive care. The coalition includes over 200 groups, representing over 150 million members.
The tenets of this work include:
- A patient’s right to dignity, autonomy, privacy, and the expectation of a trusted relationship with their clinician.
- Protection of the clinician’s ethical obligation to provide care including their access to comprehensive training.
- A commitment to an evidence-based approach to change policy (provide comprehensive training) and practice.
The Reproductive Health Coalition has collaborated to advance policies that ensure access to comprehensive reproductive care and to reframe public discourse around reproductive health with empathy and understanding.
TOWN HALLS AND SALONS on REPRODUCTIVE CARE POST-ROE
Following the Supreme Court decision on Dobbs and the overturn of Roe v. Wade, AMWA hosted a series of town halls to provide a safe space where women in medicine could come together to voice concerns, raise questions, and share stories. In many states, physicians feared repercussions from new laws that could unwittingly lead to criminal indictment while in the course of providing standard medical care. AMWA also partnered with HealthyWomen and Moms Rising in hosting public salons to help the wider community understand the complexities involved in providing reproductive care.
Past Reproductive Health Salons
- Reproductive Health Salon – Faced with Having an Abortion: 2 Women’s Experiences (Oct. 26, 2022)
- Reproductive Health Salon – Perspectives from OBGYN physicians – one who worked before abortions became legal and another who has always worked while abortion has been legal until recently.
- Marguerite Shepard, MD is a Reproductive Endocrinology & Infertility Specialist in Indianapolis, IN and has over 58 years of experience in the medical field. She graduated from Johns Hopkins U, School of Medicine medical school in 1963 and is retired Professor Emeritus of Obstetrics & Gynecology at IUSM. She practiced before abortion was legal and will speak on her experiences. She does not speak on behalf of IUSM.
- Octavia Cannon, DO is an OBGYN and past president of the American College of Osteopathic OB/GYN (ACOOG). She is a practicing physician in Michigan and has been trained and practiced when abortion has been legal.
- Moderated by Theresa Rohr-Kirchgraber, MD an internist and president of AMWA.
OTHER EVENTS
Events
- Legislative Training: Influence Skills – Legislative Conversations on Reproductive Rights (Jan. 24, 2023) Most discussions about abortion lead to debate and accusations, resulting in circular conversations that leave each person’s views more deeply engrained. This workshop will prepare you to more effectively engage conversations with legislators about reproductive rights.
- Bioethics in the Post-Roe Era: Perspectives from Clinician Ethicists (Dec. 15, 2022) Curious about the intersection of bioethics and reproductive health? Hear from two distinguished clinician ethicists, Dr. Alyssa Burgart, MD, MA (Stanford anesthesiologist) and Dr. Amanika Kumar, MD (Mayo Clinic gynecologic oncologist) about ethical issues related to abortion care in the post-Roe era, in addition to their unique career paths in clinical ethics. This is a timely and important discussion for all women in medicine —You don’t want to miss it! If you cannot join us on this date, please register so we know to provide you access to the recording after the event concludes.
- Medication Abortion 101: What It Is and How It Helps (Oct. 12, 2022) AMWA offers this program to introduce what medication abortion is and when it is appropriate. This content is intended for physicians, fellows, residents, and medical students, to be better informed about the appropriate use of this method of abortion. And, we will have a discussion of the legal implications for prescribers and patients.
- Reproductive Care and the Supreme Court Virtual Webinar (Feb. 23, 2022)
- Reproductive Care and the Supreme Court: What Dobbs v Jackson Women’s Health Organization and other cases will mean for women and their physicians.
- We will be discussing the timely and crucial topic of how the Supreme Court decision in Dobbs v Jackson Women’s Health Organization will affect women’s access to reproductive care and its impact on the physicians who treat them.
- Katie Watson, JD, Associate Professor of Medical Social Sciences, Medical Education, and Ob/Gyn, Faculty, Medical Humanities & Bioethics Graduate Program, Northwestern University Feinberg School of Medicine. A powerhouse in reproductive law and ethics, Prof. Watson has been an advocate, author, and speaker on the need for continued reproductive rights.
- Katherine McHugh, MD, Assistant Professor of Clinical Obstetrics and Gynecology, Indiana University School of Medicine, ACOG member. Dr. McHugh is a practicing OBGYN in Indiana who understands the implications of the current cases in front of the SCOTUS and that are being presented in states across the country.
ADVOCACY
Communication Strategies
On demand training: Navigating Conversations in Reproductive Care
Most discussions about abortion lead to debate and accusations, resulting in circular conversations that leave each person’s views more deeply engrained. These on-demand trainings will help you shift conversations so that people understand both the nuance and the consequences of reproductive rights.
Advocacy Timeline
2025:
October 16,2025 – AMWA signed on to the amicus brief in Planned Parenthood v Kennedy opposing Medicaid cuts that threaten access to reproductive and preventive care.
August 21, 2025 – AMWA joins the Gender Equality Coalition in opposing the proposed rollback of abortion access at the VA.
June 11, 2025 – AMWA issues Statement on Pregnancy Criminalization:
May 9, 2025 – AMWA as part of the Reproductive Health Coalition (RHC) signs onto statement on Cuts to Medicaid. The RHC shares that comprehensive healthcare access through institutions such as Medicaid ensures the health, well-being, stability, and security of our nation for generations to come
May 9, 2025 – AMWA as part of the Reproductive Health Coalition signs onto statement on Title X Cuts. The Title X federal program provides comprehensive and confidential family planning, reproductive, and sexual health care services.
January 17, 2025 – AMWA joined a letter to congressional leaders stating our strong opposition to H.R. 21/S. 6, the “Born-Alive Abortion Survivors Protection Act” as a member of the Gender Equity Alliance.
2024:
October 17, 2024 – AMWA joins amicus brief for Bryant v. Stein, a case involving North Carolina’s legislature limiting access to Mifepristone
September 2024 – AMWA joins IN vs EEOC amicus brief lead by ACOG. There is a move to remove elective abortion out of the PWFA (Pregnant Workers Fairness Act) so that time off for this medical procedure would not be protected.
March 2024 – AMWA signs on to letter supporting GenBioPro’s challenge to a West Virginia law that currently blocks patients in West Virginia from accessing mifepristone, an essential U.S. Food and Drug Administration (FDA)-approved abortion medication.
January 30, 2024 – AMWA signs on to Amicus Brief for FDA vs Alliance for Hippocratic Medicine with strong interest in protecting the autonomy of patients and clinicians evidence-based medical care and support of continued evidence-based use of mifepristone; the Amicus has been submitted to and accepted; this has been submitted to and accepted by the Supreme Court of the United States.
January 2024 – AMWA joins Amicus Brief for Gen Bio Pro vs. State of West Virginia, a case about advance provision of abortion medications before pregnancy occurs
2023:
November 21, 2023 – AMWA joins amicus brief with ACOG and other medical organization in the 353rd Judicial District Court of Travis County stating clinicians must be able to provide abortions where indicated for pregnant patients experiencing health- or life-threatening medical conditions
September 27, 2023 – AMWA Issues Statement on Abortion Bans and Impact on Treatment for Pregnancy Complications
July 2023 – AMWA signs on to letter opposing attacks on medication abortion in House Appropriations bill
June 29, 2023 – AMWA sends letter to California legislators in support of SB 345 which will help ensure the availability of abortion and gender affirming care by providing additional protections to providers who prescribe or dispense medication abortion, provide other reproductive health care services, or provide gender affirming care regardless of where their patients live.
June 24, 2023 – AMWA joins a rally in Charlotte, NC with Vice President Kamala Harris on the one year anniversary of the ruling in Dobbs v. Jackson Women’s Health Organization which overturned Roe v. Wade.
June 23, 2023 – AMWA endorses President Biden’s Executive Order on Strengthening Access to Contraception. Read the entire Executive Order
June 2023 – AMWA endorses the Right to Contraception Act reintroduced on June 14 to protect the federal right to contraception and the information made available for individuals to make safe, informed decisions about their reproductive health.
May 2023 – AMWA supports over the counter (OTC) progestin-only hormonal contraception in the U.S. without a prescription to improve reproductive care of women and those capable of becoming pregnant and asks the FDA to approve its use.
April 7, 2023 — AMWA strongly opposes the Texas decision to suspect FDA approval of mifepristone.
April 3, 2023 – AMWA joins amicus brief with the 5th Circuit in support of FDA’s approval of the use of mifepristone to end a pregnancy through ten weeks gestation
February 17, 2023 — Statement Issued: AMWA is opposed to legal interference that precludes physicians’ ability to practice evidence-based medicine and to prescribe FDA-approved medications, including Mifepristone, to patients as this can lead to preventable adverse consequences.
February 2, 2023 – AMWA signs on to Tennessee Equality Project’s statement on LGBTQ healthcare
February 2023 – Statement Issued: AMWA is opposed to any legal interference that impedes physicians’ ability to practice evidence-based medicine and to prescribe FDA-approved medications, including Mifepristone. The inability to provide essential reproductive healthcare leaves women at increased risk for adverse outcomes.
January 2023 – AMWA gave support to a bill introduced in the Illinois legislature in support of publishing the ERA Amendment to codify women’s equality and equal rights, which would also assure access to abortion care
2022:
December 2022 – AMWA signs on to letter supporting the passage of a “shield law” in New York State that would protect clinicians who want to provide telemedicine abortion into the banned and restricted states
November 28, 2022 – AMWA signed on letter to letter to legislative leaders on the importance of sexual and reproductive health priorities in the final FY23 omnibus
October 4, 2022 – AMWA submitted comment to the Department of Veterans Affairs (VA): The American Medical Women’s Association (AMWA) Military members support the provision to provide appropriate reproductive healthcare by including abortion care for all who obtain their health care at a VA facility. Abortion is an often life-saving part of health care and when a physician (or other clinician) and the patient enter into a shared decision making process, both should be assured that the care needed will be able to be rendered. When appropriate healthcare is needed, the decision on how to provide and receive that care is the purview of the patient and the physician/clinician. AMWA salutes the VA for ensuring the inclusion of abortion as health care.
October 4, 2022 – AMWA signed on to a petition calling the FDA to add miscarriage management as an indication to mifepristone’s approval, and to eliminate or modify mifepristone’s Risk Evaluation and Mitigation Strategy (REMS) so that it is not unduly burdensome for that use (Petition)
October 2022 – AMWA signs on to the women’s reproductive health letter to congressional leaders (Draft)
September 2022 – AMWA Stands with Physicians Performing Abortion Services in the Wake of Roe Being Overturned
AMWA has always upheld the right to reproductive healthcare services on behalf of both patients and physicians. AMWA fully supports physicians who are putting forth their best effort to provide abortion care that complies with current, albeit sometimes convoluted and harmful legal standards, some of which seek to punish them for doing their duty as physicians.
September 2022 – AMWA Opposes a National Ban on Abortion After 15 Weeks
The proposed national ban on abortion after 15 weeks is not based on medical science and introduces intrusion into the patient-physician relationship. The American Medical Women’s Association (AMWA) ardently opposes the legislation of health care, including abortion and other reproductive care.
August 9, 2022 – AMWA participated with Doctors for America’s (DFA) FDA Task Force in a letter to Secretary Becerra thanking him for protecting patients across the country with the recent Executive Order safeguarding access to reproductive health care services. Doctors for America’s (DFA) FDA Task Force and the American Medical Women’s Association (AMWA) support the Administration’s work to ensure that Americans are able to obtain the healthcare they need without barriers. The letter also included additional recommendations on how to further protect and expand access to reproductive care
August 2022 – AMWA Opposes Legislative Limits to Abortion
The American Medical Women’s Association (AMWA) is dedicated to the advancement of reproductive health and supports access to safe and legal abortion as part of comprehensive reproductive health care for all. We oppose legislation that limits access to abortion, such as that recently passed in Indiana.
July 2022 – AMWA Endorses Presidential Executive Order to Protect Reproductive Rights
The American Medical Women’s Association (AMWA) supports the efforts made by President Biden to protect access to reproductive health services announced in an Executive Order today. In particular, AMWA upholds the commitment to safeguard reproductive rights, specifically to:
- Protect access to FDA-approved medication abortion Ensure that patients are able to receive emergency medical care related to pregnancy and miscarriage
- Enable interstate travel to attain abortion care and maintain access to contraception
- Protect the privacy of an individual’s health information, including reproductive health information
May 10, 2022 – AMWA signs on to letter to the Senate supporting passage of the Women’s Health Protection Act
May 2022 – AMWA Continues to Support Reproductive Rights for All Including Access to Safe and Legal Abortions
The American Medical Women’s Association (AMWA) has advocated for comprehensive reproductive health throughout its history and remains committed to supporting reproductive rights for all patients, including access to safe and legal abortions.
May 2022 – AMWA Supports Access to Safe and Legal Abortion
As an organization dedicated to the advancement of reproductive health, the American Medical Women’s Association (AMWA) supports access to safe and legal abortion as part of comprehensive reproductive health care for all.
March 28, 2022 – AMWA joins a second amicus brief with ACOG regarding Montana Planned Parenthood and restrictive access to abortion.
March 2022 – AMWA joins ACOG in the amicus brief for Planned Parenthood of Minnesota, North Dakota, and South Dakota v. Noem (21-2913), currently before the 8th Circuit, that challenges a 2011 South Dakota law requiring patients to visit a “Pregnancy Help Center” (PHC)
March 2022 – AMWA joins ACOG in the amicus brief for Planned Parenthood of Montana v. Montana, DA 21-0521 that challenges three abortion restrictions passed by the legislature and signed by the governor in 2021 (the laws are currently enjoined and not in force)
February 1, 2022 – AMWA signs on to letter urging Senators to support the Women’s Health Protection Act (S. 1975)